DOCU vs EDIT · P/E 15, rev $2.98B vs rev $32.3M
DocuSign Inc (DOCU) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the DOCU and EDIT stock pages for the full models.
Not investment advice.